What Blood Tests Should Men On TRT Get?
Timeline
Timestamp
Topic
00:00
A 62-year-old man who has used TRT for 30 years asks which blood tests men on testosterone should routinely monitor.
01:03
Dr. O’Connor broadens the question beyond laboratory testing and explains why hypertension, cardiovascular disease, stroke, kidney disease, and other long-term risks matter when testosterone is used for decades.
05:00
The ABCDs™ framework is introduced as a structured way for men on testosterone to monitor metabolic, cardiovascular, and blood-related risks instead of focusing only on hormone levels.
05:50
Dr. O’Connor begins outlining focused blood testing and explains why men already established on TRT need a different monitoring strategy than men being evaluated for low testosterone for the first time.
07:09
Specific monitoring panels are discussed, including comprehensive metabolic testing, CBC with iron studies, and versions with or without testosterone and estradiol depending on whether hormone measurements are actually needed.
11:27
Dr. O’Connor recommends periodic monitoring of A1C, blood pressure, cholesterol, CBC, and iron studies while explaining androgen-induced erythrocytosis, phlebotomy, sleep apnea, and other factors that can affect red blood cell measurements.
Video Summary
A 62-year-old man on long-term TRT asks which blood tests he should monitor and how often. Dr. O’Connor explains that laboratory monitoring should be focused on the health risks that matter most rather than repeatedly ordering large panels without a clear purpose. For men already established on testosterone, he emphasizes the ABCDs™ framework, including A1C, blood pressure, cholesterol and cardiovascular risk, and iron deposition or depletion related to androgen-induced erythrocytosis.
The discussion covers comprehensive metabolic testing, CBC with iron studies, hemoglobin A1C, lipid testing, PSA, thyroid testing, urinalysis, vitamin D, and when testosterone and estradiol measurements are actually useful. Dr. O’Connor also explains why the timing of testosterone blood work must correspond with the injection schedule, particularly when interpreting peak and trough levels with testosterone cypionate or enanthate.
Long-term safety remains the larger goal. Dr. O’Connor discusses hypertension, cardiovascular disease, chronic kidney disease, sleep apnea, excess weight, erythrocytosis, and excessive phlebotomy while emphasizing that men on TRT should understand what their results mean and use them to guide prevention rather than simply collecting laboratory numbers.
Drug Callouts
Drug
Description
Testosterone
The member has used testosterone replacement therapy for approximately 30 years and currently takes 100 mg weekly divided between Monday and Thursday. Dr. O’Connor explains that long-term testosterone monitoring should include cardiovascular, metabolic, kidney, prostate, and red blood cell health rather than repeatedly checking testosterone levels alone.
Testosterone Cypionate
Testosterone cypionate is discussed while explaining the pharmacokinetics of injectable testosterone and why blood-test timing affects measured testosterone levels. Dr. O’Connor emphasizes evaluating levels near the appropriate trough rather than reacting to a predictable post-injection peak.
Testosterone Enanthate
Testosterone enanthate is discussed alongside cypionate as a longer-acting testosterone ester with predictable rises and falls after injection. Dr. O’Connor uses these pharmacokinetics to explain why injection frequency and the timing of laboratory testing must be considered together.
Condition Callouts
Condition
Description
Hypertension
Dr. O’Connor repeatedly identifies hypertension as a major modifiable risk for men using testosterone long term. Because elevated blood pressure contributes to heart disease, stroke, kidney disease, and erectile dysfunction, he considers regular blood pressure monitoring a fundamental part of TRT safety.
Cardiovascular Disease
Cardiovascular disease is a major focus because the member has used testosterone for decades and is now 62 years old. Dr. O’Connor emphasizes monitoring blood pressure, A1C, cholesterol, and other cardiovascular risks so long-term TRT management addresses disease prevention rather than hormone levels alone.
Chronic Kidney Disease
Chronic kidney disease is discussed as one of the serious long-term consequences associated with uncontrolled cardiovascular risk, particularly hypertension. For men on testosterone, Dr. O’Connor includes kidney function within routine metabolic testing and the broader ABCDs™ monitoring strategy.
Androgen-Induced Erythrocytosis
Androgen-induced erythrocytosis is discussed as the testosterone-related increase in red blood cell production that can raise hemoglobin and hematocrit. Dr. O’Connor emphasizes evaluating CBC results together with iron studies and avoiding excessive phlebotomy that may deplete iron stores.
Sleep Apnea
Sleep apnea is identified as an important hypoxic stimulus that can further increase red blood cell production in men using testosterone. Dr. O’Connor recommends considering sleep apnea, body weight, and possible CPAP or BiPAP treatment when erythrocytosis becomes a concern.
Erectile Dysfunction
Erectile dysfunction is discussed as one potential consequence of vascular disease and uncontrolled hypertension rather than simply a testosterone problem. Dr. O’Connor uses this connection to emphasize why men on TRT should closely monitor blood pressure and cardiovascular health.
Key Takeaways
- Men established on long-term TRT need focused health monitoring rather than repeatedly ordering broad laboratory panels without a clear clinical purpose.
- The ABCDs™ framework directs attention toward A1C, blood pressure, cholesterol and cardiovascular risk, and androgen-related red blood cell and iron abnormalities.
- CBC results should be evaluated with iron studies because hemoglobin and hematocrit alone do not provide a complete picture of androgen-induced erythrocytosis.
- Testosterone blood levels must be interpreted according to injection timing because cypionate and enanthate produce predictable peaks and troughs after each dose.
- Long-term TRT monitoring should include metabolic, cardiovascular, kidney, prostate, thyroid, urinary, and blood-related health rather than testosterone and estradiol alone.
- Sleep apnea, excess weight, testosterone injections, and repeated phlebotomy can all affect red blood cell and iron measurements in men on TRT.